Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broncho-Vaxom in adults with chronic rhinosinusitis
2007-005152-16Phase 4Completed
- Sponsor
- OM Pharma
- Start
- Feb 2008
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of OM-85 in chronic rhinosinusitis (CRS), rhinosinusitis, sponsored by OM Pharma. Started Feb 2008; status: completed.
02
Drugs
OM-85
03
Conditions
chronic rhinosinusitis (CRS)rhinosinusitis
Beyond the preview
Go deeper on 2007-005152-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005152-16.